Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Nevilledog

(51,120 posts)
Tue Jul 14, 2020, 09:50 PM Jul 2020

Moderna...says its coronavirus vaccine trial produced 'robust' immune response

Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced ‘robust’ immune response


https://www.cnbc.com/2020/07/14/moderna-says-its-coronavirus-vaccine-trial-produced-robust-immune-response-in-all-patients.html


Moderna’s shares soared after the company said its potential vaccine to prevent Covid-19 produced a “robust” immune response in all 45 patients in its early stage human trial, according to newly released data published Tuesday evening in the peer-reviewed New England Journal of Medicine.

Moderna’s stock rose more than 16% in after-hours trading on the news.

All 45 patients produced neutralizing antibodies, which scientists believe is important for building immunity and provided more promising data that the vaccine may give some protection against the coronavirus. In the trial, each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. Participants received two doses of the potential vaccine.

After two vaccinations, the vaccine elicited a “robust” immune response in all participants in all dose cohorts, Moderna said. The company said the levels of neutralizing antibodies in patients in the high dose group were fourfold higher than in recovered Covid-19 patients.

“These Phase 1 data demonstrate that vaccination with mRNA-1273 elicits a robust immune response across all dose levels and clearly support the choice of 100 µg in a prime and boost regimen as the optimal dose for the Phase 3 study,” Moderna’s chief medical officer, Tal Zaks, said in a statement. “We look forward to beginning our Phase 3 study of mRNA-1273 this month to demonstrate our vaccine’s ability to significantly reduce the risk of COVID-19 disease.”

*snip*
8 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Moderna...says its coronavirus vaccine trial produced 'robust' immune response (Original Post) Nevilledog Jul 2020 OP
politics aside RT Atlanta Jul 2020 #1
Encouraging news. I hope those antibodies last SoonerPride Jul 2020 #2
It's T cells that last. I think. triron Jul 2020 #4
This is good news. The question now is how long the immune response lasts. LonePirate Jul 2020 #3
It my understanding that he mRNA vaccines work to give longer lived immunity Thekaspervote Jul 2020 #5
When a story begins "Moderna's shares soared after the company said...," I think pump & dump PSPS Jul 2020 #6
Tried to get that in the title but too long. That's why I put full title in post. Nevilledog Jul 2020 #7
This is definitely good news. Initech Jul 2020 #8

RT Atlanta

(2,517 posts)
1. politics aside
Tue Jul 14, 2020, 09:51 PM
Jul 2020

whatever is going to be promising, clinically tested, with verifiable results, I am all for it.

here's to hoping some of these trials advance to something meaningful that will save lives.

LonePirate

(13,424 posts)
3. This is good news. The question now is how long the immune response lasts.
Tue Jul 14, 2020, 09:58 PM
Jul 2020

Does the response last for a few weeks? A few months? A year? Longer? Basically, will the vaccine be something most people take once, like the MMR shot? Or will we need to receive yearly (or bi-yearly) vaccinations?

Thekaspervote

(32,774 posts)
5. It my understanding that he mRNA vaccines work to give longer lived immunity
Tue Jul 14, 2020, 10:12 PM
Jul 2020

The m standing for memory, i.e. the virus is recognized longer as an invader and an attack is launched to stop it

Nevilledog

(51,120 posts)
7. Tried to get that in the title but too long. That's why I put full title in post.
Tue Jul 14, 2020, 10:21 PM
Jul 2020

It always feels skeevy talking about stock prices for developing a vaccine for a pandemic.

Initech

(100,080 posts)
8. This is definitely good news.
Tue Jul 14, 2020, 10:25 PM
Jul 2020

Now we need to see how long the immune response lasts before we can pop the champagne.

Latest Discussions»General Discussion»Moderna...says its corona...